ANEBULO PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.8 USD | +6.06% |
|
+36.65% | +15.70% |
Chart calendar Anebulo Pharmaceuticals, Inc.
c9a4068f896a6922f3368880544301b.Hq3LITFn4Qp-uv-iYq256ykE0aqceRIFCLjRSDjfxrw.dIC7aVstoFhM3M_XBdz7kXF8gNrkK1hIPteoJ06Zjc4mlf1pZAjWfyiJug~b6c6d98a0b99d9132c1c1ba6960a0639
Upcoming events on Anebulo Pharmaceuticals, Inc.
Past events on Anebulo Pharmaceuticals, Inc.
| 15/05/2024 18:05 | Q3 2024 Earnings Release |
| 13/02/2024 21:05 | Q2 2024 Earnings Release |
| 19/11/2023 | Annual General Meeting |
| 14/11/2023 21:05 | Q1 2024 Earnings Release |
| 10/10/2023 20:30 | American Emergency Physicians Congress |
| 09/10/2023 15:30 | American Emergency Physicians Congress |
| 04/10/2023 16:30 | LD Micro Main Conference |
| 29/09/2023 18:00 | North American Clinical Toxicology Congress |
| 20/09/2023 21:29 | Q4 2023 Earnings Release |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 22/06/2023 16:30 | Maxim Group Virtual Healthcare Conference |
| 04/06/2023 | BIO International Convention |
| 11/05/2023 13:00 | Q3 2023 Earnings Release |
| 23/03/2023 14:00 | Sidoti Spring Small-Cap Conference |
| 10/02/2023 13:38 | Q2 2023 Earnings Release |
| 05/02/2023 | BIO CEO and Investor Conference |
| 08/01/2023 | JP Morgan Healthcare Conference |
| 30/11/2022 | Benchmark Company Discovery Investor Conference |
| 10/11/2022 13:00 | Q1 2023 Earnings Release |
| 28/10/2022 17:00 | Annual General Meeting |
Annual results
| Fiscal Period | June | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -3,61 -5,70 36.6% | -6,83 -6,29 -8.56% | -11,8 -12,2 3.46% | -11,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -30,3 -5,89 -413.63% | -6,83 -6,29 -8.54% | -11,7 -12,2 3.46% | -11,8 |
|
Net income Million USD | Released Forecast Spread | -38,5 -5,89 -552.99% | -6,83 -6,29 -8.54% | -11,7 -12,2 3.46% | -11,8 |
|
EPS USD | Released Forecast Spread | -2,83 -0,30 -843.33% | -0,29 -0,27 -7.41% | -0,47 -0,48 2.08% | -0,44 |
| Announcement Date | 22/09/21 | 09/09/22 | 20/09/23 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,88 -1,27 -47.88% | -2,33 -1,79 -30.13% | -2,61 -2,51 -3.98% | -3,81 -2,83 -34.88% | -2,86 -4,07 29.67% | -2,49 -2,92 14.48% | -2,54 -3,03 16.01% | -2,76 -2,59 -6.52% | -1,66 -3,04 45.22% | -3,59 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,88 -1,27 -47.41% | -2,32 -1,79 -30.09% | -2,61 -2,51 -4.03% | -3,83 -2,83 -35.37% | -2,80 -4,07 31.33% | -2,50 -2,92 14.53% | -2,48 -3,01 17.65% | -2,72 -2,56 -6.09% | -1,65 -3,01 45.01% | -3,56 |
|
Net income Million USD | Released Forecast Spread | -1,88 -1,27 -47.41% | -2,32 -1,79 -30.09% | -2,61 -2,51 -4.03% | -3,83 -2,83 -35.37% | -2,80 -4,07 31.33% | -2,50 -2,92 14.53% | -2,48 -3,01 17.65% | -2,72 -2,56 -6.09% | -1,65 -3,01 45.01% | -3,56 |
|
EPS USD | Released Forecast Spread | -0,08 -0,05 -60% | -0,10 -0,08 -33.33% | -0,11 -0,11 -4.76% | -0,15 -0,11 -36.36% | -0,11 -0,16 29.03% | -0,10 -0,11 9.09% | -0,10 -0,12 14.29% | -0,11 -0,10 -10% | -0,06 -0,12 48.57% | -0,12 |
| Announcement Date | 11/05/22 | 09/09/22 | 10/11/22 | 10/02/23 | 11/05/23 | 20/09/23 | 14/11/23 | 13/02/24 | 15/05/24 | - |
| 15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
| 21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 26/07/2024 06:00 | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Anebulo Pharmaceuticals, Inc.
| 07/06/2024 07:57 | POLARIS GROUP: May 2024 Sales and Revenue Release |
| 29/05/2024 21:01 | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
| 22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
| 21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
| 21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
| 15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANEB Stock
- Calendar Anebulo Pharmaceuticals, Inc.
